6篇
您的检索式：作者名="Vallier AL"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patients显示文摘 | Gounaris l Provenzano E Vallier AL et a/ | 2011 | Breast Caner Res Treat2011，127，2： | 1 |
| 2 | Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant se- quential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer(Neo-tAnGo) : an open-label, 2 : 2 factorial randomised phase 3 trial显示文摘 | Earl HM Vallier AL Hiller L | 2014 | Lancet Oncol2014，15，2： | 1 |
| 3 | Effects of the addi- tion of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast can- cer (Neo-tAnGo): an open-label, 22 factorial randomised phase 3 trial显示文摘 | Earl HM Vallier AL Hiller L | 2014 | Lancet Oncol2014，15，2： | 1 |
| 4 | Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patients显示文摘 | Gounaris I Provenzano E Vallier AL | 2011 | Breast Cancer Res Treat2011，127，2： | 1 |
| 5 | Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2x2 factbrial randomised phase 3 trial 显示文摘 | Earl HM Vallier AL Hiller L | 2014 | Lancet Oncol2014，15，2： | 1 |
| 6 | Effects of the addition of gem- citabine, and paetitaxel-first sequencing,in neoadjuvant sequential epimbicin, eyclophosphamide, and paelitaxel for women with high- risk early breast eaneer(Neo-tAnGo) :an open-label,2x2 faetorial randomised phase 3 trial 显示文摘 | Earl HM Vallier AL Hiller L | 2014 | Lancet Oncol2014，15，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员